HomeBUSINESS
BUSINESS

Eisai’s Midterm Strategy Focusing on Neurology, Oncology “Gradually Producing Results”: CEO Naito
(Nov.2.2016)

Eisai CEO Haruo Naito
Eisai’s strategy focusing on neurology and oncology set in its midterm business plan, dubbed “EWAY 2025” kicked off in April, “is gradually producing results,” stressed CEO Haruo Naito at an earnings briefing on October 31. “Particularly, we see steady progress in our pipeline,” he added ...
(LOG IN FOR FULL STORY)

News Calendar